ETON
Eton Pharmaceuticals Records Impressive Q1 2026 Performance with Record Product Sales and Exciting New Launches
Eton Pharmaceuticals, a leading player in the rare disease space, has reported an impressive set of financial results for the first quarter of 2026. In a conference call to discuss the company's quarterly performance, CEO Sean Brynjelsen highlighted the significance of these results, stating that the first quarter